The following is a review of diagnostic product developments worldwideThe information is updated the first week of every month - so ... make this a regular stop in your information gathering activities.
The following information has been compiled from publicly available sources, StratCom does not assume any responsibility for the accuracy or the authenticity of the information and StratCom cannot be held liable for errors.
Product developments in February 2007
3M acquired Acolyte Biomedica, manufacturer of the BacLite Rapid system, an automated microbial detection platform that aids in the rapid detection, diagnosis, and treatment of infectious diseases. In January 2006, Acolyte launched a rapid culture-based MRSA test, BacLite Rapid, which can detect the presence or absence of MRSA direct from clinical samples in less than five hours.
BD Biosciences and Roche formed a collaboration to identify and develop intracellular phosphorylation site antibodies that will improve their understanding of the pathways that carry information inside of cells and why these pathways sometimes malfunction to cause disease. The goal is the discovery of new drugs and biological markers for life-threatening conditions.
Beckman Coulter exercised its option to continue to license patent rights relating to the use of High Mobility Group Box 1 (HMGB1) technology from Critical Therapeutics. HMGB1 is an emerging marker for acute and chronic diseases resulting in multi-organ failure, including sepsis and septic shock, chronic inflammatory diseases, and rheumatoid arthritis.
Cytyc Corporation is buying Adeza Biomedical Corporation for $452 million. Adeza's key product, FullTerm, The Fetal Fibronectin Test, is used to identify women at risk of preterm birth.
Gynecor introduced TruTest that uses a gentle brushing technique to collect a uterine biopsy from the patient in the physicians' office. The specimen is then returned to Gynecor where it is tested by tissue histology, cytology and HPV genotyping.
Idaho Technology launched its Razor system a POC device capable of performing DNA-based pathogen detection in 30 minutes. It utilizes a real-time PCR plastic freeze-dried reagent format where samples are loaded with syringes into cartridges.
Inverness Medical completed its third acquisition in a month. The acquisitions include: First Check Diagnostics’ OTC products for drugs, alcohol, cholesterol and FOB; Promesan SRL, an Italian distributor of medical diagnostics products; and Canadian distributor Med-Ox Chemicals.
Quest Diagnostics acquired HemoCue, specializing from the private equity firm EQT II B.V. in a cash transaction valued at approximately $420 million. The acquisition will allow Quest Diagnostics to enter the growing near patient testing market
Quidel and Cholestech joined forces to offer the Accu-Tame program to dermatologists as a tool in prescribing isotretinoin, an acne treatment that carries a significant risk of birth defects if taken during pregnancy. The prescribing label requires that they test patients for pregnancy and lipids and liver enzymes.
SpheroSense Technologies is developing a disposable, continuous-monitoring device for the early detection of sepsis. The biosensor can detect circulating small molecules, drugs, proteins, viruses, DNA and RNA
Product developments - January 2007
Product Developments Worldwide | Research News | Health Care in Canada
Information Technology and Healthcare | Molecular Biology | Links
Send mail to firstname.lastname@example.org with questions or comments about this web site.
Concept and Design Blue Page
Last modified: March 04, 2007